Literature DB >> 10724128

Hormonal side effects in women: typical versus atypical antipsychotic treatment.

R A Dickson1, M V Seeman, B Corenblum.   

Abstract

Neuroleptic-induced hyperprolactinemia can cause menstrual disorders, impaired fertility, galactorrhea, and sexual dysfunction, as well as hypoestrogenism secondary to disruption of the hypothalamic-pituitary-ovarian axis. The development of the prolactin-sparing atypical antipsychotic drugs offers prevention and resolution of these adverse reactions. Thus far, this property of the new medications has received insufficient clinical attention. The authors use case vignettes to discuss assessment and management of clinical situations that arise as a result of antipsychotic-induced endocrine changes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10724128

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  12 in total

1.  Possible individual and gender differences in the small increases in plasma prolactin levels seen during clozapine treatment.

Authors:  Jose de Leon; Francisco J Diaz; Richard C Josiassen; George M Simpson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2004-10       Impact factor: 5.270

2.  The association between CYP2D6 genotype and switching antipsychotic medication to clozapine.

Authors:  Jochem G Gregoor; Karen van der Weide; Jan van der Weide; Harold J G M van Megen; Antoine C G Egberts; Eibert R Heerdink
Journal:  Eur J Clin Pharmacol       Date:  2013-07-07       Impact factor: 2.953

Review 3.  Premenstrual exacerbation of mental health disorders: a systematic review of prospective studies.

Authors:  Louise Nora Nolan; Liz Hughes
Journal:  Arch Womens Ment Health       Date:  2022-07-22       Impact factor: 4.405

4.  Efficacy and tolerability of olanzapine in patients with schizophrenia in lithuania: A 13-week, multicenter, open-label, nonrandomized study.

Authors:  Valentinas Maciulis; Istvan Bitter; Raimundas Milasiunas; Algirdas Dembinskas; Liaudminas Radavicius; Algirdas Kaunas; Martin Dossenbach; Daniel Walker
Journal:  Curr Ther Res Clin Exp       Date:  2004-01

5.  Gender dimorphism in siblings with schizophrenia-like psychosis due to Niemann-Pick disease type C.

Authors:  M Walterfang; M Fietz; L Abel; E Bowman; R Mocellin; D Velakoulis
Journal:  J Inherit Metab Dis       Date:  2009-07-17       Impact factor: 4.982

Review 6.  Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences.

Authors:  Chien-Yu Chen; Hsien-Yuan Lane; Chieh-Hsin Lin
Journal:  Clin Psychopharmacol Neurosci       Date:  2016-08-31       Impact factor: 2.582

7.  Hyperprolactinaemia with amisulpride.

Authors:  Rajnish Raj; Balwant Singh Sidhu
Journal:  Indian J Psychiatry       Date:  2008-01       Impact factor: 1.759

8.  Low dose quetiapine induced galactorrhoea: a case report.

Authors:  Maneesh Gupta
Journal:  Clin Pract Epidemiol Ment Health       Date:  2007-07-24

9.  Treating symptomatic hyperprolactinemia in women with schizophrenia: presentation of the ongoing DAAMSEL clinical trial (Dopamine partial Agonist, Aripiprazole, for the Management of Symptomatic ELevated prolactin).

Authors:  Deanna L Kelly; Heidi J Wehring; Amber K Earl; Kelli M Sullivan; Faith B Dickerson; Stephanie Feldman; Robert P McMahon; Robert W Buchanan; Dale Warfel; William R Keller; Bernard A Fischer; Joo-Cheol Shim
Journal:  BMC Psychiatry       Date:  2013-08-22       Impact factor: 3.630

10.  The Effects of Chlorpromazine on Reproductive System and Function in Female Rats.

Authors:  Zahra Zamani; Samad Zare; Rajabali Sadrkhanlou; Abbas Ahmadi; Elham Movahed
Journal:  Int J Fertil Steril       Date:  2015-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.